|
Status |
Public on Nov 28, 2018 |
Title |
Extrinsic C5a Activation Regulates Squamous Carcinogenesis and Limits Clonal T Cell Responses to Chemotherapy (Blood) |
Organism |
Mus musculus |
Experiment type |
Other
|
Summary |
In the K14-HPV16 transgenic mouse model of squamous carcinogenesis, activation of C5a receptor (C5aR1) in early neoplastic tissues fosters protumorigenic properties of C5aR1+ mast cells and macrophages, and in turn, suppression of CD8+ T cell cytotoxicity. Therapeutic inhibition of C5a receptor (C5aR1) with a peptide antagonist improved efficacy to paclitaxel chemotherapy associated with CXCR3-dependent CD8+ T cell activation. To investigate the effects of combination therapy on the T cell repertoire, we performed deep sequencing of the complementarity-determining region (CDR) 3 of the T cell receptor (TCR)b chain in matched tumor lysates and peripheral blood mononuclear cells (PBMCs). Intratumoral TCRβ clonotypes were hyperexpanded and increasingly detected in matched peripherally-expanded T cell populations, thereby implicating antigen-dependent peripheral priming in response to systemic C5aR1 inhibition.
|
|
|
Overall design |
Deep sequencing of the complementarity-determining region (CDR) 3 of the T cell receptor (TCR)b chain in matched tumor lysates and peripheral blood mononuclear cells (PBMCs)
|
|
|
Contributor(s) |
Medler T, Murugan D, Horton W, Kumar S, Cotechini T, Forsyth A, Leyshock P, Leitenberger J, Kulesz-Martin M, Margolin A, Werb Z, Coussens L |
Citation(s) |
30300579 |
|
Submission date |
Mar 26, 2018 |
Last update date |
Jan 30, 2020 |
Contact name |
Lisa Coussens |
E-mail(s) |
coussenl@ohsu.edu
|
Organization name |
OHSU
|
Street address |
SW Sam Jackson Park Rd
|
City |
Portland |
State/province |
Oregon |
ZIP/Postal code |
97239 |
Country |
USA |
|
|
Platforms (1) |
GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
|
Samples (44)
|
|
This SubSeries is part of SuperSeries: |
GSE112323 |
Extrinsic C5a Activation Regulates Squamous Carcinogenesis and Limits Clonal T Cell Responses to Chemotherapy |
|
Relations |
BioProject |
PRJNA445687 |
SRA |
SRP136451 |